Case report: Successful use of ruxolitinib to treat interstitial pneumonia as an unusual primary presentation in primary myelofibrosis—two birds with one stone
Anemia and interstitial pneumonia both significantly improved following treatment with a Janus kinase 2 gene inhibitor. In this report, we discuss the possible mechanisms underlying PMF complicated with ILD.
Authors
- Junnan Su (ORCID: https://orcid.org/0000-0003-4660-2069)
- Pingping Xiao (ORCID: https://orcid.org/0000-0001-5542-4730)
- Zhi-Gao Dong
- Yi Lin (ORCID: https://orcid.org/0000-0002-1556-6416)
- Qingqing Wang (ORCID: https://orcid.org/0000-0002-6950-0631)
- Yongquan Chen (ORCID: https://orcid.org/0000-0003-3475-652X)
Institutions
- The Second Affiliated Hospital of Xiamen Medical College
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-26
- DOI
- https://doi.org/10.3389/fonc.2024.1475036
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00